Back to Sleep and Sudden Infant Death Syndrome (SIDS)
Sudden Infant Death Syndrome (SIDS) is defined as “the sudden death of an infant under one year of age which remains unexplained after a thorough case investigation, including a complete autopsy, examination of the death scene, and review of the clinical history.”
During my time at the University of Virginia, I trained under neonatologist Dr. John Kattwinkel, a champion for newborn health and one of the leading figures in shaping national safe sleep policies. In the early 1990s, he chaired the American Academy of Pediatrics (AAP) Task Force on Infant Sleep Position and SIDS, which laid the foundation for the landmark Back to Sleep campaign.
At that time, SIDS claimed roughly 14 infants per 10,000 live births in 1988. Following the campaign’s launch in 1994, the rate plummeted by over 60%, reaching about 5 deaths per 10,000 live births by 2006. Despite this dramatic improvement, recent data suggest that the decline has plateaued.....
Dr. M

Today on Dr. M’s Women and Children First Podcast, we welcome Dr. Wayne Koontz, a founding partner at Salisbury Pediatric Associates in Salisbury North Carolina, where he has spent over 5 decades caring for generations of families with compassion, wisdom, and a deep commitment to community health.
Dr. Koontz earned his Undergraduate degree and his Doctor of Medicine from Wake Forest University, where his early love of science and service began to take shape. He went on to complete his pediatric residency at Dallas Children’s Medical Center, part of the University of Texas Southwestern Medical School, where he received outstanding training in both academic and clinical pediatrics.
As one of the founding physicians at Salisbury Pediatrics, Dr. Koontz helped to build a model of child-centered, family-oriented care that has served the Rowan County. His commitment to children’s well-being extends beyond the clinic, reflecting a lifelong dedication to preventive medicine, developmental health, and the nurturing of strong physician–family relationships.
It’s an honor to have Dr. Koontz with us today to share his clinical insights as they relate to infection and vaccination from a longevity based pediatric career. Dr. Koontz has a unique perspective to share as his 50 plus years of experience cover the prevaccine infectious disease based practice of pediatric medicine all the way to the current vaccine centric and reduced infectious disease burden reality. That is a timeline worthy of exploration.
So lets explore.
Dr. M

Speaking Truth in Love: The Weight of Avoidance in Pediatric Metabolic Health
After completing the second round of our Asthma and Obesity Metabolic Pilot Program at Salisbury Pediatrics, I left the clinic reflecting deeply on what I witnessed. It crystallized a truth that is uncomfortable but undeniable: the greatest health threats to our children today are not infectious or accidental, they are metabolic. Diseases once reserved for adulthood: insulin resistance, fatty liver, hypertension, early vascular aging are now appearing in children who should be free to run, play, and thrive.
In modern society, conversations about weight and metabolic dysfunction have become relatively taboo. This is not to say that children of normal or low weight are immune; they, too, can be at risk. However, the excess-weight group carries the highest statistical burden. Too often, clinicians hesitate to speak truth to families for fear of offending, shaming, or overstepping. In doing so, we risk silence becoming complicity and allowing preventable disease to take root in the very children we are charged to protect.
Much of this epidemic is not born of individual failure but of systemic neglect. Government-funded, poor-quality school meals, cheap processed foods, and relentless marketing of sugar and refined carbohydrates have built an environment where metabolic injury is almost inevitable. When a child’s daily fuel is engineered for shelf life instead of cell life, the outcome is not accidental, it is predictable. Our pilot program lab results are a painful window into that truth.... and a literature review on eczema and anaphylaxis.
Enjoy Dr. M

Review Part III - after the Attia Podcast
After completing the interview with Dr. William Parker and now listening to Peter Attia's analysis, let us look again at this question. I repeat that the initial question has not changed for me. The first and most fundamental question to ask is this: What is the true value of acetaminophen in health compared with the potential risk if the associated findings are indeed correct?
My response to this question has been altered by the analysis so far.
I love this from Dr. Attia: "Some people might be wondering, why did you just take so long to explain all this to us? Why don’t you just give us the answer? I just want the sound bite, man
Peter’s reply, “If you just want sound bites, you’re never going to learn.”
Honestly, if you just want sound bites, this isn’t the podcast for you. But if you actually want to be able to learn to think for yourself, then that’s what we’re here to do. And that’s the reason we killed ourselves over the past week to put together the most thorough gathering of all the data we could find and the most intense night-weekend analysis possible. "
I agree! I believe that the science and data are key. So here goes - round three!.....
Dr. M
 

Welcome to Dr. M’s Women & Children First Podcast, where we engage with pioneering voices at the intersection of science, healthcare, and the well-being of families.

Today on Dr. M’s Women and Children First, we welcome Dr. Elizabeth Mumper, a physician, educator, and thought leader whose career has profoundly influenced the practice of integrative pediatrics.

Dr. Mumper earned her Bachelor of Science degree from Bridgewater College, graduating magna cum laude, before attending the Virginia Commonwealth University School of Medicine, where she received her medical degree. She completed her pediatric residency at the University of Virginia and served as Chief Resident in Pediatrics. She remained at UVA as an Associate Professor of Clinical Pediatrics from 1997 to 2005, mentoring future physicians and advancing holistic, evidence-based approaches to child health.

Following her time in academia, Dr. Mumper founded The Rimland Center for Integrative Medicine in Lynchburg, Virginia, a clinic dedicated to children with autism spectrum disorders, PANS/PANDAS, allergies, and complex chronic illnesses. Her practice integrates the best of conventional pediatrics with biomedical and functional medicine principles, always guided by compassion and curiosity.

She has been a leading educator with the Medical Academy of Pediatric Special Needs (MAPS) and a frequent international lecturer, teaching clinicians how to recognize and treat the root causes of immune dysregulation, inflammation, and neurodevelopmental challenges.

Dr. Mumper is also the author of the new book Kids and COVID, an insightful exploration of how the pandemic impacted children, physically, emotionally, and developmentally, and what lessons medicine must learn moving forward. In our conversation, we discuss her book in depth, as well as the broader implications of the COVID-19 pandemic for pediatric care, resilience, and future public health policy.

Finally, we dive into the complex topic of vaccines, considering what we’ve learned from the pandemic years and expanding the conversation begun with Dr. Paul Offit and Dr. Joel Warsh.

Dr. Mumper’s lifelong dedication to children, her fearless pursuit of truth, and her balanced, science-driven voice make her one of the most respected figures in functional medicine.

Please join me in welcoming my friend and colleague,  Dr. Elizabeth Mumper.

Dr. M

Flu season is around the corner and we should take a look at the virus for preparation purposes.
Influenza
Every few years, I revisit this virus in my writing, not only to keep it on your radar in preparation, but also because of the significant illness and death it continues to cause. It’s never wise to dismiss its potential impact. Influenza reliably returns each year, difficult to escape even with strict isolation.
The flu is different from the common cold in many ways as the flu has:
1) Rapid onset with high spiking fevers
2) Muscle and headaches
3) Little to not sneezing and sore throat
4) Rapid and robust cough onset
Influenza season is beginning in the United States this fall. Who gets sick? In short, people of all ages. Seasonal influenza has a reproductive rate of just over one, meaning that each infected person typically spreads the virus to one or two others through coughing or sneezing in close proximity. The virus also survives on surfaces for up to 24 hours, creating another common route of transmission, especially in children. Young kids frequently touch surfaces and each other, then touch their faces, providing the perfect pathway for infection. Because of this, schools remain a major hub for flu transmission across the country.
Preventing the virus from taking root in your body is the key to avoiding a bad outcome.
Things that I think of as critical to avoiding or preventing this infection:
1) Keeping your vitamin D level greater than 50 ng/ml is an important way to prevent influenza infections. Get tested and supplement accordingly. As always the sun is your natural route to normal D levels
2) Get adequate sleep based on your age to keep your immune system in great shape. Sleep is very important for immune health...... and more on asthma driving mental health issues.
Dr. M

Welcome to Dr. M’s Women & Children First Podcast, where we engage with pioneering voices at the intersection of science, healthcare, and the well-being of families.
Today, I’m honored to introduce Dr. William Parker, PhD. Dr. Parker is perhaps best known for discovering the function of the human appendix, but his contributions to science extend far beyond that single discovery. He studied biology and chemistry as an undergraduate before earning his PhD in Chemistry from the University of Nebraska–Lincoln in 1992. Since the 1980s, he has conducted innovative research, publishing more than 150 peer-reviewed articles that span immune function, microbiome science, and human health.
Dr. Parker was the first to compare immune systems in wild animals with those of their laboratory counterparts, and among the first to conclude that changes in the human “biota”, the symbiotic organisms living within us, brought on by modern society can contribute to depression and anxiety. After nearly three decades at Duke University, where he served as associate professor and research leader, he founded WPLab, Inc., a nonprofit dedicated to understanding and educating about the causes of chronic inflammatory diseases in high-income societies.
Currently a visiting scholar at the University of North Carolina, Dr. Parker collaborates widely with colleagues from Duke University, University of Montreal, Czech Academy of Sciences, University of Groningen, University of Colorado Boulder, and scientists across the pharmaceutical industry.
In recent years, he has turned his attention to a provocative and urgent question: the potential links between early acetaminophen exposure and autism spectrum outcomes. His current work combines mechanistic and epidemiologic approaches to explore how acetaminophen’s effects on human physiology at critical stages of development might influence neurodevelopment.
In our conversation, we’ll explore:


The evidence and hypotheses behind acetaminophen’s potential role in autism risk
What families and clinicians should know: what’s plausible, what remains speculative, and where research is heading next

I’m thrilled to share this episode with Dr. Parker, whose intellectual curiosity, scientific rigor, and courage to ask difficult questions embody the spirit of this show.
Dr. M

For parents of special needs children, I honor you today.
I witness your strength every day in clinic.
You rise to meet challenges that many cannot begin to imagine, truly. You navigate medical appointments, therapy sessions, school meetings, and the unpredictable rhythms that come with raising a child with special needs.
Often without pause, without adequate rest, and without the recognition you deserve. For those single parents carrying this day to day reality, a double level of gratitude for you.
I want to pause for a moment and say what is too rarely said: you are extraordinary. Truly extraordinary.
Your love is not passive, it is an active force. It shows up at 2 AM when a child can’t sleep, in the quiet patience during a meltdown, in the persistence to advocate for services in a dysfunctional system requiring resilience summoned when the system says “no” but you know your child needs a “yes.”.... and a discussion of nutritional dark matter.
Enjoy,
Dr. M

Welcome back to Dr. M’s Women & Children First, where we explore the front lines of children’s health and what matters most for our families.
Today I’m honored to bring you Dr. Paul A. Offit, the Director of the Vaccine Education Center and Professor of Pediatrics in the Division of Infectious Diseases at Children’s Hospital of Philadelphia. He also holds the Maurice R. Hilleman Professorship of Vaccinology at the University of Pennsylvania.
Dr. Offit is a globally recognized expert in virology and immunology. He has served on the CDC’s Advisory Committee on Immunization Practices and FDA’s Vaccines and Related Biological Products Advisory Committee. He’s co-editor of the seminal vaccine textbook Vaccines, and for decades has been one of the clearest scientific voices defending evidence, transparency, and children’s health.
This week, we’ll dig into COVID, vaccine policy, and what’s ahead for children in light of the latest shifts. Among current headlines: Healthy children and pregnant women are no longer being uniformly recommended for COVID vaccines by Health Secretary Robert F. Kennedy Jr., a decision that’s stirring debate among pediatricians and public health experts like Dr. Offit. He’s sharply voiced concerns about removing key vaccine recommendations without new data, and about the broader implications of loosening vaccine guidance for the public good.
In this conversation, we’ll cover:



What the science says now about bivalent COVID vaccines in kids


How recent policy changes affect vaccine access, trust, and safety


What parents need to know—what’s changed, what’s stable, and what remains uncertain


This is my third time talking with Dr. Offit, and as always, I expect you’ll leave with clarity, evidence, and questions worth sharing.
I hope you enjoy this conversation.
Let’s dive in.
Dr. M

Breastmilk is Dynamic
Cellular and transcriptional diversity over the course of human lactation
This recent 2022 paper in the Proceedings of the National Academy of Sciences by Dr. Nyqiust and colleagues is a site for sore eyes.
It offers a remarkable, high-resolution portrait of how the cellular landscape of human breast milk (hBM) shifts over time. The authors capture something both scientifically rich and uniquely human: the dynamic, living composition of milk as it adapts to the changing needs of mother and child.
The abstract: "Human breast milk is a dynamic fluid that contains millions of cells, but their identities and phenotypic properties are poorly understood. We generated and analyzed single-cell RNA-sequencing (scRNA-seq) data to characterize the transcriptomes of cells from hBM across lactational time from 3 to 632 d postpartum in 15 donors. We found that the majority of cells in hBM are lactocytes, a specialized epithelial subset, and that cell-type frequencies shift over the course of lactation, yielding greater epithelial diversity at later points. Analysis of lactocytes reveals a continuum of cell states characterized by transcriptional changes in hormone-, growth factor-, and milk production-related pathways. Generalized additive models suggest that one subcluster, LC1 epithelial cells, increases as a function of time postpartum, daycare attendance, and the use of hormonal birth control. We identify several subclusters of macrophages in hBM that are enriched for tolerogenic functions, possibly playing a role in protecting the mammary gland during lactation. Our description of the cellular components of breast milk, their association with maternal–infant dyad metadata, and our quantification of alterations at the gene and pathway levels provide a detailed longitudinal picture of hBM cells across lactational time. This work paves the way for future investigations of how a potential division of cellular labor and differential hormone regulation might be leveraged therapeutically to support healthy lactation and potentially aid in milk production." (Nyquist et. al. 2022)
And more information on breastmilk immunology and a recipe.
Dr. M

Welcome back to Dr. M’s Women and Children First podcast where we look at the world of Women and Children's Health through an anthropological lens with the humble understanding that we have a lot to learn.

Today, I’m joined by Dr. Joel “Dr. Gator” Warsh, a pediatrician, author, and advocate for a whole-child approach to healthcare. Dr. Warsh earned his medical degree from Thomas Jefferson Medical College and completed his pediatric residency at Children’s Hospital of Los Angeles. Along the way, he also obtained a Master’s degree in Epidemiology and Biostatistics from Queen’s University in Canada, giving him a strong foundation in both clinical care and population health. These educational pursuits make him uniquely suited for today's conversation on vaccines.

He is the author of Between a Shot and a Hard Place. In his own words, he says: I’ve dedicated my career to helping families navigate complicated health topics with clarity. My book addresses vaccine questions in a calm, data-driven, and practical way, offering parents guidance that steers clear of extremes. Parents face unprecedented pressure to make the "right" choices, often without enough balanced information. He has been featured on major platforms sharing his message with more than 400,000 parents through social media. We discuss his passion for empowering families to make informed, individualized decisions, including in areas that have been challenging or even taboo to discuss.

Today, we’ll dive into his latest work, his perspectives on vaccines and preventative care, and how he envisions a future of pediatrics that is proactive rather than reactive. This is a conversation about rethinking the foundations of child health and it’s one you won’t want to miss.

Enjoy,

Dr. M

Inflammaging from a Population View
In a landmark study published in Nature Aging on July 7, 2025, researchers challenge a cornerstone of modern gerontology by showing that inflammaging, chronic, age-associated low-grade inflammation, is not universal across all human populations. The abstract states the following: "Inflammaging, an age-associated increase in chronic inflammation, is considered a hallmark of aging. However, there is no consensus approach to measuring inflammaging based on circulating cytokines. Here we assessed whether an inflammaging axis detected in the Italian InCHIANTI dataset comprising 19 cytokines could be generalized to a different industrialized population (Singapore Longitudinal Aging Study) or to two indigenous, nonindustrialized populations: the Tsimane from the Bolivian Amazon and the Orang Asli from Peninsular Malaysia.

We assessed cytokine axis structure similarity and whether the inflammaging axis replicating the InCHIANTI result increased with age or was associated with health outcomes. The Singapore Longitudinal Aging Study was similar to InCHIANTI except for IL-6 and IL-1RA. The Tsimane and Orang Asli showed markedly different axis structures with little to no association with age and no association with age-related diseases. Inflammaging, as measured in this manner in these cohorts, thus appears to be largely a byproduct of industrialized lifestyles, with major variation across environments and populations." (Franck et. al. 2025)

The research team analyzed 19 cytokines in over 2,800 individuals from four diverse populations: two industrialized cohorts: Italy's InCHIANTI and the Singapore Longitudinal Aging Study (SLAS); two non-industrialized, Indigenous groups: the Tsimane of the Bolivian Amazon and the Orang Asli of Peninsular Malaysia.

In Italy and Singapore, the industrialized regions noted classic inflammaging signatures with inflammatory markers like IL‑6, TNF-α, and CRP increased with age, and correlated strongly with age-related chronic diseases such as cardiovascular and kidney disease..... and more on inflammaging...

Dr. M

A Rooted Approach to Modern Medicine: The Vision Forward
My emerging and chronically iterating philosophy of medicine is a rising structural entity rooted between ancient healing wisdom and modern scientific insight. It is layered with root cause immunometabolomic thinking and built upon anthropological foundations. As a pediatrician, educator, and onion peeling thinker, I believe that a medical approach grounded in compassion, prevention, and the pursuit of root causes is the way forward. Medicine is not just about treating disease but about reshaping the very terrain in which illness arises. This can and must start with our women and children.
At the heart of this vision is a belief in the power of systems biology and our deep interconnectedness. The human body cannot be understood or healed through isolated parts or siloed provider experiences. We must move beyond symptom suppression and toward an understanding of the why behind disease. Why does a child struggle with allergies, ADHD, or autoimmune illness? What factors in the environment, diet, stress response, or microbial ecosystem have altered their trajectory? Why are the governmental and NGO leaders not guiding us towards a benevolent goal of whole child health? These are the questions that shape and guide our practice....and a literature review.
Dr. M

Today’s guest is Dr. Sanjay Bhojraj, a powerful voice at the crossroads of advanced interventional cardiology and root-cause wellness. Dr. Bhojraj is board-certified in Cardiovascular Diseases and Interventional Cardiology, and one of only a small number of interventional cardiologists in the United States who is also certified in Functional Medicine through the Institute for Functional Medicine.
Dr. Bhojraj earned his medical degree from Indiana University School of Medicine, trained in internal medicine at Northwestern, and completed a cardiology fellowship at the renowned Henry Ford Health System. For over two decades, he practiced in conventional cardiology, saving lives daily with stents, angioplasties, and transcatheter valve replacements.
But along the way, something essential began to stir. He found himself asking bigger questions: Why do people arrive in the cath lab in the first place? Why are we not doing more to prevent the first or second heart event? And what role do nutrition, sleep, stress, and emotional health truly play in long-term cardiovascular outcomes?
These questions led Dr. Bhojraj to Functional Medicine, not as an alternative, but as an evolution, a model that restores agency to patients and equips the body to heal through comprehensive lifestyle optimization. He now leads the Well12 Program, a transformational experience that guides individuals in upgrading the foundational systems of their health from metabolism to mindset, so they can live not just longer, but better.
Today, Dr. Bhojraj and I explore the remarkable protein Klotho and the emerging science linking it to human longevity and health span. This is a conversation you won’t want to miss, a glimpse into what may become a defining frontier in upstream disease prevention.
Enjoy,
Dr. M

Systemic Maternal Inflammation and Neurodevelopment: The Role of IL-6 and IFN-γ in Autism Spectrum Disorder
I just returned from Estes Park, Colorado where I presented a lecture on the Growing Brain/Mind - a tour through the underpinnings of childhood neurological changes that we call Autism. The timing is perfect for this article to be written.
In an era when chronic disease in children is rising at an unprecedented pace, the search for root causes must include an honest inquiry into the conditions present during fetal development. The review article by Majerczyk and colleagues, Systemic Maternal Inflammation Promotes ASD via IL-6 and IFN-γ, brings forward a critical piece in this puzzle that I began to explore a few years ago when writing a book. It connects the dots between maternal immune dysregulation and long-term neurodevelopmental outcomes, specifically autism spectrum disorder (ASD). Through a synthesis of clinical data and animal research, the authors make a compelling case for the centrality of two inflammatory messengers, interleukin-6 (IL-6) and interferon-gamma (IFN-γ), in shaping fetal brain development during gestational stress. The key words here being GESTATIONAL STRESS, the recurring scientific theme for ASD development, not vaccines... and some literature reviews.
Dr. M

Today, we explore the intersections of cutting-edge science, compassionate care, and the future of pediatric and maternal health with Dr. Melinda Elliott, MD, FAAP, a leading neonatologist and the Chief Medical Officer at Prolacta Bioscience. Dr. Elliott has dedicated her career to advancing the care of our most vulnerable patients, premature and medically fragile infants, through both clinical excellence and research-driven innovation.




Dr. Elliott earned her medical degree from West Virginia University School of Medicine. She went on to complete her residency in pediatrics and her fellowship in neonatal-perinatal medicine at the University of Florida, where she also served as chief resident and a faculty member, helping to train the next generation of pediatricians and neonatologists.



Throughout her clinical and leadership career, Dr. Elliott has been deeply involved in advancing evidence-based care in the NICU, improving nutritional strategies for preterm infants, and advocating for human milk as a therapeutic intervention in neonatal health. Her work with Prolacta Bioscience supports NICUs around the globe in providing 100% human milk–based nutrition to reduce complications such as necrotizing enterocolitis (NEC), a devastating condition that disproportionately affects preterm infants.



Please join me in welcoming Dr. Melinda Elliott, a champion for babies and a voice for innovation in neonatal medicine.
Dr. M

As I have told many of my patients, I would write immediately when NC sees its first Measles case.
Well, North Carolina has its first measles case: The North Carolina Department of Health and Human Services has confirmed a case of measles in a child who was visiting Forsyth and Guilford counties. The child became ill while traveling to NC from another country where measles outbreaks have recently been reported. To protect the individual and their family’s privacy, no additional information about this individual will be released. This is the first confirmed case of measles in the state in 2025. NCDHHS is recommending all unvaccinated individuals ages one year and older receive measles vaccination to protect themselves and those around them. (NCDHHS)

So, it is finally in NC. If you are still on the fence of whether to vaccinate, the issue is now truly pressing.
From the CDC:
U.S. Hospitalizations in 2025
12% of cases hospitalized (148 of 1227)

Percent of Age Group Hospitalized

Under 5 years: 20% (72 of 355 cases) 50% of the total hospitalized. Highest risk bucket.

5-19 years: 8% (35 of 455)

20+ years: 10% (40 of 404)

Age unknown: 8% (1 of 13)

Deaths 3

And a story on Insurance Hell.

Enjoy,
Dr. M

Literature Review
1) An exciting phase three trial with the CETP inhibitor Obicetrapib has shown serious promise for ASCVD and Alzheimer's Disease (AD). "In BROADWAY, a pre-specified AD sub-study was designed to assess plasma AD biomarkers in patients enrolled in the BROADWAY trial and evaluated the effects of longer duration of therapy (12 months) with a prespecified population of ApoE3/4 or 4/4 carriers. The sub-study included 1727 patients, including 367 ApoE4 carriers. The primary outcome measure was p-tau217 absolute and percent change over 12 months. Additional outcome measures included neurofilament light chain (“NFL”), glial fibrillary acidic protein (“GFAP”), p-tau181, and Aβ42/40 ratio absolute and percent change over 12 months. NewAmsterdam observed statistically significant lower absolute changes in p-tau217 compared to placebo over 12 months in both the full ITT population (p<0.002) and in ApoE4 carriers (p=0.0215)." (NAMS)

Obicetrapib has shown significant LDL and Lp(a) lowering effects as well in early trials. I will be watching this discovery closely as it may be a game changer for these diseases. "In the BROADWAY trial, more than 2,500 participants with established heart disease or genetic high cholesterol were given either Obicetrapib or a placebo, in addition to their regular cholesterol medications. After 12 weeks, those on Obicetrapib had dropped their LDL cholesterol by 32.6 per cent and Lp(a) by 33.5 per cent on average – many achieved guideline-recommended targets for the first time." (Sci Tech Daily) The drop in Lp(a) is the profound result as this is a massive risk factor for ASCVD and to date is not moveable by statins and most used meds.

2) GLP1 drugs and risk for macular degeneration?... and more

Dr. M

Today’s guest is Lisa Danahy, a powerhouse in the world of yoga therapy, trauma-informed education, and social-emotional learning. With over three decades of experience as a school administrator, curriculum designer, and wellness educator, Lisa brings a rare blend of clinical insight, compassion, and practical tools to help children and the adults who care for them find calm in a chaotic world.

Lisa holds a Master of Science in Yoga Therapy, is a certified yoga therapist and educator, and is the founder of Create Calm, a nationally recognized nonprofit that’s transformed wellness access for neurodiverse, disabled, and underserved youth across the country. Since 2016, Create Calm has delivered evidence-based programs to thousands of students, educators, and families in school systems nationwide.

Lisa’s approach integrates the latest research in psychology, neuroscience, and movement science into accessible practices that support emotional regulation, resilience, and whole-person healing. She's a Hay House author, international speaker, and a trusted trainer for clinicians, caregivers, and teachers alike.

Stay with us as we explore how her work is redefining wellness in schools, clinics, and communities.

You can learn more about Lisa’s work at www.CreateCalm.org and www.MondayMindfulness.com.

Let’s dive in.

Please Enjoy,

Dr. M

There is a quiet truth written in the tomes of family life that science keeps confirming over and over. It’s worth pausing to reflect on.
A warm bond between a father and child lights a path toward a steady, grounded adulthood. Studies show kids with an emotionally present dad, someone who’s there with a hug or a knowing nod, are less likely to stumble into behavioral trouble. Boys, especially, often look to their fathers as a mirror, shaping themselves in the image of a dad they feel close to. It’s a simple gift: presence breeds strength, presence breeds exploration of self, presence breeds knowing, presence breeds growth in all things for men.
Now, here’s a twist you might not expect. The old-school image of the rugged, masculine dad, stoic and commanding, was once thought to mold boys into the same mold. But research, like a wise teacher, reveals otherwise. A boy’s masculinity isn’t forged by a father’s stern hand; it’s an innate spark, flickering or bold regardless of style. As a Stoic father might counsel, we can’t control the nature we’re given, only how we nurture it. So, let’s release the pressure to force a mold and instead guide with patience. This theory follows the excellence of The Carpenter and the Gardener by Gopnik.... and a recipe.
Enjoy
Dr. M